Cancer Deaths Are Falling in the U.S. While Cases Keep Rising. Here’s the Public Health Story Behind the Split

Cancer remains one of the world’s biggest health challenges. It caused nearly 10 million deaths globally in 2024, and an estimated 20.6 million new cases were diagnosed that same year. Yet inside those enormous numbers is a striking public health story: in the United States, cancer death rates have continued to fall even as new cancer case rates have edged upward.

That split suggests that progress is real, but incomplete. People are more likely to survive many cancers than in the past, especially as prevention, screening, and treatment improve. At the same time, the overall burden of cancer remains extremely high, with 1,941,540 invasive cancers diagnosed in the U.S. in 2023 alone.

For public health, this is not a contradiction. It is the clearest sign of where cancer control is working, where the burden is still growing, and where policy can make the biggest difference next.

Fewer people are dying from cancer, and lung cancer helps explain why

The CDC’s 2026 Annual Report to the Nation found that U.S. cancer death rates declined from 2019 to 2023. A major reason was a drop in lung cancer deaths.

This is one of the strongest examples of public health success in cancer control. Lung cancer remains the leading cause of cancer death worldwide, but it is also a disease strongly shaped by prevention. Reducing tobacco use changes cancer risk across entire populations. Over time, those changes show up not just in surveys or clinic visits, but in death rates.

That is what makes lung cancer so important from a policy perspective. Public health measures such as tobacco control can shift disease trajectories on a national scale. When fewer people start smoking, more people quit, and exposure falls across communities, the effect reaches far beyond individual choice. It changes mortality patterns.

Why rising case counts do not cancel out this progress

Even with falling death rates, cancer is still being diagnosed at very high levels. The CDC report found that new cancer case rates in the U.S. rose slightly from 2018 to 2022. National surveillance data also show nearly 1.94 million invasive cancers diagnosed in 2023.

For health systems, this means demand is not easing. More people still need screening, diagnosis, treatment, follow-up care, and survivorship support. A falling death rate is good news, but it does not reduce the need for oncology capacity, patient navigation, palliative care, or prevention programs.

At the population level, incidence and mortality measure different parts of the cancer story. Incidence tells us how many people are developing cancer. Mortality tells us how many are dying from it. When mortality falls faster than incidence, prevention and care are often making a difference, but the underlying burden remains large.

A large share of cancer is still preventable

One of the most important facts in cancer control is also one of the most actionable: a substantial share of cancer burden can be prevented.

According to the World Health Organization, nearly one quarter of cancer deaths are linked to tobacco, alcohol, high body mass index, low fruit and vegetable intake, and physical inactivity. In low- and lower-middle-income countries, infections such as HPV and hepatitis account for about 30% of cancer cases.

These are not marginal risk factors. They are major drivers of disease. They also point directly to public health interventions that can reach large populations:

Tobacco control reduces exposure to the leading avoidable cause of cancer death. Vaccination and infection control can prevent cancers linked to HPV and hepatitis. Policies that support access to healthy food, physical activity, and healthier weight can reduce risk across multiple diseases, including cancer.

This is why cancer prevention cannot be treated as a narrow clinical issue. It is tied to taxation, regulation, immunization programs, school and workplace environments, food systems, and access to primary care.

The global burden shows why prevention has to be central

Globally, the scale of cancer remains enormous. The International Agency for Research on Cancer and the American Cancer Society estimated 20.6 million new cancer cases and 9.8 million deaths in 2024. The most commonly diagnosed cancers worldwide were lung, breast, colorectal, prostate, and stomach cancer. Lung cancer was also the leading cause of cancer death.

Those figures are more than a snapshot. They show that cancer control is now a defining challenge for health systems worldwide. Countries are facing not only the need for better treatment, but also the need to build prevention into national health strategy.

This matters because the cancers driving the heaviest burden are not shaped by the same risks. Some are strongly linked to tobacco. Others are influenced by infections, diet, body weight, or access to screening and timely treatment. Effective cancer policy therefore has to be broad enough to address shared risk factors while targeted enough to respond to specific local patterns.

What this means for public health policy now

The current cancer picture calls for a two-track response.

First, public health systems need to keep accelerating what is already working. The decline in U.S. cancer death rates shows that prevention and better care can shift outcomes at scale. Tobacco control remains central, especially because its benefits ripple across multiple cancers and other major diseases.

Second, health systems have to prepare for sustained demand. High and slightly rising cancer incidence means millions of people will continue to need services. This includes screening infrastructure, diagnostic capacity, treatment access, long-term follow-up, and survivor support.

Public health leaders must think globally and locally at the same time. In some settings, infection-related cancers remain a major share of the burden, making HPV and hepatitis prevention especially important. In others, the biggest opportunities may come from tobacco control, obesity prevention, or improving access to cancer detection and care.

The real story is progress with pressure

The most useful way to understand cancer right now is not as a single trend moving in one direction. It is a story of progress under pressure.

Deaths are falling in the United States, which is a meaningful public health achievement. But cancer is still diagnosed on a vast scale, and the global burden remains immense. That combination should sharpen, not soften, the policy response.

The lesson is clear: prevention works, early action matters, and population-level policies can save lives. The next phase of cancer control will depend on how well countries turn those lessons into durable systems that reduce risk, catch disease earlier, and make effective care reachable for everyone who needs it.